European Journal of Cancer
Volume 39, Issue 6 , Pages 748-754 , April 2003

An economic evaluation of the optimal workload in treating surgical patients in a breast unit

  • E Pagano

      Affiliations

    • Unit of Cancer Epidemiology, University of Turin and CPO-Piemonte, Via Santena 7, 10126 Turin, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39-011-633-6855; fax: +39-011-670-6692
  • ,
  • A Ponti

      Affiliations

    • Unit of Cancer Epidemiology, Ospedale S. Giovanni Battista and CPO-Piemonte, Via San Francesco da Paola 31, 10123 Turin, Italy
  • ,
  • E Gelormino

      Affiliations

    • Unit of Cancer Epidemiology, University of Turin and CPO-Piemonte, Via Santena 7, 10126 Turin, Italy
  • ,
  • F Merletti

      Affiliations

    • Unit of Cancer Epidemiology, University of Turin and CPO-Piemonte, Via Santena 7, 10126 Turin, Italy
  • ,
  • M.P Mano

      Affiliations

    • Department of Biomedical Sciences and Human Oncology, University of Torino, Via Santena 7, 10126 Turin, Italy

Received 25 March 2002 ,Revised 13 August 2002 ,Accepted 23 October 2002.

References 

  1. Roohan PJ, Bickell NA, Baptiste MS, Therriault GD, Ferrara EP, Siu AL. Hospital volume differences and five-year survival from breast cancer. Am. J. Public Health. 1998;3:454–457
  2. Sainsbury R, Haward B, Rider L. Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet. 1995;345:1265–1270
  3. Gillis CR, Hole DJ. Survival outcome of care by specialist surgeons in breast cancer (a study of 3786 patients in the west of Scotland). Br. Med. J. 1996;312:145–148
  4. NHS Centre for Review Dissemination . The management of primary breast cancer. Effective Health Care. 1996;6:1–16
  5. O'Higgins N, Linos DA, Blichert-Toft M, et al.  European guidelines for quality assurance in the surgical management of mammographically detected lesions. Eur. J. Surg. Oncol. 1998;24:96–98
  6. Cataliotti L, Costa A, Daly PA, et al.  Florence Statement on Breast Cancer, Forging the way ahead for more research on and better care in breast cancer. Eur. J. Cancer. 1998;35:14–15
  7. Piccart M, Cataliotti L, Buchanan M, et al.  Brussels Statement document. Eur. J. Cancer. 2001;37:1335–1337
  8. Ma M, Bell J, Campbell S, Basnett I, Pollock A, Taylor I (on behalf of the Clinical Advisory Panel). Breast Cancer management: is volume related to quality? Br J Cancer 1997, 11, 1652–1659.
  9. Gabel M, Hilton NE, Nathanson D. Multidisciplinary breast cancer clinics (do they work?). Cancer. 1997;79:2380–2384
  10. Hebert-Croteau N, Brisson J, Pineault R. Review of organisational factors related to care offered to women with breast cancer. Epidemiol Rev. 2000;2:228–238
  11. Sainsbury R, Rider L, Smith A, MacAdam A (on behalf of the Yorkshire Breast Cancer Group). Does it matter where you live? Treatment variation for breast cancer in Yorkshire. Br J Cancer 1995, 71, 1275–1278.
  12. Chaudry R, Goel V, Sawka C. Breast cancer survival by teaching status of the initial treating hospital. Can. Med. Assoc. J. 2001;164:183–188
  13. Gregory WM, Smith P, Richards MA, Twelves CJ, Knigth RK, Rubens RD. Chemotherapy of advanced breast cancer (outcomes and prognostic factors). Br. J. Cancer. 1993;68:988–995
  14. Richards M, Sainsbury R, Kerr D. Inequalities in breast cancer care and outcome. Br. J. Cancer. 1997;5:634–638
  15. Chouillet AM, Bell CMJ, Hiscox JG. Management of breast cancer in south-east England. Br. Med. J. 1994;308:168–171
  16. Grilli R, Minozzi S, Tinazzi A, Labianca R, Sheldon TA, Liberati A. Do specialists do it better? The impact of specialisation on the process and outcomes of care for cancer patients. Ann. Oncol. 1998;9:365–374
  17. Scottish Intercollegiate Guidelines Network. Breast Cancer in Women. A National Clinical Guidelines. Edinburgh, Scotland, 1998.
  18. NHMR National Breast Cancer Center. Clinical Practice Guidelines for the Management of Early Breast Cancer. Second Stage Consultation, Canberra, 2000.
  19. Cancer Guidance Sub-group of the Clinical Outcomes Groups . Improving Outcomes in Breast Cancer. The Evidence. London: NHS Executive; 1996;
  20. EUSOMA . The requirements of a specialist breast unit. Eur. J. Cancer. 2000;36:2288–2293
  21. NHS Centre for Review Dissemination . Hospital volume and health care outcomes, costs and patients access. Effective Health Care. 1996;2:1–16
  22. Regione Piemonte. Assessorato alla Sanità. Tumore della mammella. Linee guida clinico organizzative per la regione Piemonte. Torino, 2002.
  23. Ciatto S, Del Turco MR, Marrazzo A, et al.  Time trends of benign/malignant breast biopsy ratios (a multicenter Italian study). Tumori. 1996;82:325–328
  24. Perry NM  the EUSOMA Working Party . Quality assurance in the diagnosis of breast disease. Eur. J. Cancer. 2001;37:159–172
  25. CPO Centro di riferimento per l'Epidemiologia e la Prevenzione Oncologica in Piemonte. http://www.cpo.it/dationcologici/174-175.pdf (accessed 5 August 2002).
  26. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas D. Cancer Incidence in Five Continents, vol. VIII. WHO, International Agency for Research on Cancer, IARC Scientific Publications, Lyon [in press].
  27. In:  Zanetti R,  Gafà L,  Pannelli F,  Conti E,  Rosso S editor. Cancer in Italy. Incidence Data from Cancer Registries. vol. 3. Roma: Il Pensiero Scientifico Editore; 2002;

PII: S0959-8049(02)00808-0

doi: 10.1016/S0959-8049(02)00808-0

European Journal of Cancer
Volume 39, Issue 6 , Pages 748-754 , April 2003